AstraZeneca is one of the top global pharmaceutical companies in the world, with over 83,000 employees worldwide.

AstraZeneca K.K. was established in 2000 with the merger of Astra Japan K.K with Zeneca K.K., and now employs 3,400 people, with a turnover of 3,5 billion USD.

Under the "Ambition Zero Carbon" program, AstraZeneca has set the goal of reaching zero carbon emissions from operations by 2025, and for its whole value chain to be carbon negative from 2030, investing up to 1 billion USD. A key step to reaching these goals is to switch the entire AstraZeneca car fleet - 17,000 vehicles - to fully electric vehicles.